Br Med J (Clin Res Ed) 1985;291:930-932 (5 October), doi:10.1136/bmj.291.6500.930
Extrapyramidal reactions with metoclopramide.
D N Bateman,
M D Rawlins,
J M Simpson
The epidemiology of extrapyramidal reactions to metoclopramide
was studied by examining reports in the Adverse Reactions Register
of the Committee on the Safety of Medicines and comparing these
with prescribing figures by general practitioners in the United
Kingdom for metoclopramide (Maxolon). In the period 1967-82
there were an estimated 15.9 million prescriptions and 479 reports
of extrapyramidal reactions (455 of dystonia-dyskinesia, 20
of parkinsonism, and four of tardive dyskinesia). When corrected
for prescribing rates the relative risk of dystonia and dyskinesia
was 1.8 in female compared with male patients (95% confidence
interval 1.4-2.2). The overall reporting rate for dystonia and
dyskinesia was 28.6/million prescriptions but was significantly
more common in young adults (p less than 0.0001) and especially
girls and women aged 12-19 (190.7 reports/million prescriptions).
By contrast parkinsonian reactions were significantly more common
in the elderly (p less than 0.0001).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
This article has been cited by other articles:
-
TOUSI, B.
(2008). Movement disorder emergencies in the elderly: Recognizing and treating an often-iatrogenic problem. Cleveland Clinic Journal of Medicine
75: 449-457
[Abstract]
[Full text]
-
Dingli, K., Morgan, R., Leen, C.
(2007). Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ
334: 899-900
[Full text]
-
Sweeney, B. J., Edgecombe, J., Churchill, D. R., Miller, R. F., Harrison, M. J. G.
(1994). Choreoathetosis/Ballismus Associated With Pentamidine-Induced Hypoglycemia in a Patient With the Acquired Immunodeficiency Syndrome. Arch Neurol
51: 723-725
[Abstract]
-
Ganzini, L., Casey, D. E., Hoffman, W. F., McCall, A. L.
(1993). The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders. Arch Intern Med
153: 1469-1475
[Abstract]
-
Sewell, D. D., Jeste, D. V.
(1992). Metoclopramide-Associated Tardive Dyskinesia: An Analysis of 67 Cases. Arch Fam Med
1: 271-278
[Abstract]
-
Miller, L. G., Jankovic, J.
(1989). Metoclopramide-Induced Movement Disorders: Clinical Findings With a Review of the Literature. Arch Intern Med
149: 2486-2492
[Abstract]
-
Brower, R. D., Dreyer, C. F., Kent, T. A.
(1989). Neuroleptic Malignant Syndrome in a Child Treated With Metoclopramide for Chemotherapy-Related Nausea. J Child Neurol
4: 230-232